Drug Profile
Research programme: recombinant proteins - Neumedicines
Alternative Names: hHSS1 - Neumedicines; HSS1 - Neumedicines; NMHSS1; Recombinant haematopoietic signal peptide containing secreted 1 - NeumedicinesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Neumedicines
- Class Recombinant proteins
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Glioma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Glioma in USA (Parenteral)
- 01 Apr 2011 Preclinical trials in Glioma in USA (unspecified route)